Survival Probability (95% Confidence Interval) | ||||||||||
Total Population | White | Black | Other | Unknown | ||||||
Number | Percentage | Number | Percentage | Number | Percentage | Number | Percentage | Number | Percentage | |
5-Year Survival | ||||||||||
Sample Size | 25,652 | 67.5% | 21,143 | 67.4% | 1791 | 63.8% | 2455 | 69.6% | 263 | 87.2% |
Age at diagnosis | ||||||||||
0 - 19 years | 15,971 | 87.5% | 12,973 | 87.7% | 1122 | 83.6% | 1496 | 87.7% | 200 | 95.4% |
20 - 39 years | 3611 | 48.9% | 2949 | 48.8% | 232 | 40.0% | 391 | 55.8% | 39 | 47.4% |
40 - 59 years | 3271 | 34.6% | 2700 | 34.4% | 248 | 29.0% | 308 | 39.4% | 15 | 83.3% |
>60 years | 2979 | 16.5% | 2521 | 16.3% | 189 | 14.8% | 260 | 18.8% | 9 | 55.6% |
Diagnosis era | ||||||||||
2000-2009 | 12,047 | 65.4% | 10,091 | 65.6% | 840 | 61.1% | 1059 | 66.7% | 57 | 80.9% |
2010-2019 | 13,605 | 69.6% | 11,052 | 69.3% | 951 | 66.2% | 1396 | 72.0% | 206 | 91.1% |
Sex | ||||||||||
Male | 14,522 | 67.3% | 12,053 | 67.0% | 986 | 64.8% | 1329 | 70.4% | 154 | 85.5% |
Female | 11,130 | 67.8% | 9090 | 67.9% | 805 | 62.5% | 1126 | 68.7% | 109 | 89.5% |
All phenotypes | ||||||||||
T-cell | 2221 | 65.5% | 1,660 | 67.6% | 305 | 57.2% | 242 | 60.8% | 14 | 77.9% |
B-cell | 18,068 | 68.1% | 15,080 | 67.8% | 1114 | 66.5% | 1728 | 69.9% | 146 | 89.0% |
Unknown lineage | 2534 | 62.7% | 2157 | 62.6% | 179 | 53.9% | 177 | 72.1% | 21 | 80.0% |
Other | 2829 | 69.9% | 2246 | 68.6% | 193 | 66.7% | 308 | 83.3% | 82 | -- |
10-Year Survival | ||||||||||
Sample Size | 25,652 | 64.0% | 21,143 | 63.8% | 1791 | 60.2% | 2455 | 66.5% | 263 | 86.1% |
Age at diagnosis | ||||||||||
0 - 19 years | 15,971 | 84.7% | 12,973 | 84.9% | 1122 | 80.8% | 1496 | 84.9% | 200 | 95.4% |
20 - 39 years | 3611 | 44.3% | 2949 | 44.0% | 232 | 33.9% | 391 | 52.7% | 39 | -- |
40 - 59 years | 3271 | 28.7% | 2700 | 28.4% | 248 | 23.5% | 308 | 34.8% | 15 | 55.5% |
>60 years | 2979 | 10.6% | 2521 | 10.3% | 189 | 8.7% | 260 | 14.4% | 9 | 55.6% |
Diagnosis era | ||||||||||
2000-2009 | 12,047 | 62.0% | 10,091 | 62.1% | 840 | 57.7% | 1059 | 63.3% | 57 | 80.9% |
2010-2019 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Sex | ||||||||||
Male | 14,522 | 63.4% | 12,053 | 63.1% | 986 | 60.8% | 1329 | 66.8% | 154 | 83.7% |
Female | 11,130 | 64.7% | 9090 | 64.7% | 805 | 59.4% | 1126 | 66.1% | 109 | 89.5% |
All phenotypes | ||||||||||
T-cell | 2221 | 63.3% | 1660 | 65.5% | 305 | 55.6% | 242 | 57.1% | 14 | 77.9% |
B-cell | 18,068 | 64.3% | 15,080 | 63.9% | 1114 | 62.3% | 1728 | 67.1% | 146 | 87.5% |
Unknown lineage | 2534 | 59.6% | 2157 | 59.5% | 179 | 51.1% | 177 | 67.4% | 21 | 80.0% |
Other | 2829 | 67.5% | 2246 | 65.5% | 193 | 66.7% | 308 | 83.3% | 82 | -- |